about
Topical Drug Delivery for Chronic Rhinosinusitis.Smart Polymers in Nasal Drug DeliveryAn overview of clinical and commercial impact of drug delivery systemsUltrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.Electrophoretic particle guidance significantly enhances olfactory drug delivery: a feasibility studyFocused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats.Insulin, cognition, and dementiaTat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.Airflow and nanoparticle deposition in rat nose under various breathing and sniffing conditions: a computational evaluation of the unsteady effect.Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylateHigh resolution visualization and analysis of nasal spray drug delivery.Bacterial biofilms in patients with chronic rhinosinusitis: a confocal scanning laser microscopy study.Administration of substances to laboratory animals: routes of administration and factors to consider.The importance of chemistry in creating well-defined nanoscopic embedded therapeutics: devices capable of the dual functions of imaging and therapy.Emerging technologies that overcome biological barriers for therapeutic protein delivery.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice.Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route.Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.Deviated nasal septum hinders intranasal sprays: a computer simulation studyObesity-induced increases in sympathetic nerve activity: sex mattersA Computational Study of Nasal Spray Deposition Pattern in Four Ethnic Groups.N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats.The application of mucoadhesive polymers in nasal drug delivery.Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodentsLiposomes as delivery systems for nasal vaccination: strategies and outcomes.Polysaccharide drug delivery systems based on pectin and chitosan.Insulin resistance and pathological brain ageing.A review on mucoadhesive polymer used in nasal drug delivery system.Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.Basics and recent advances in peptide and protein drug delivery.Nasal-nanotechnology: revolution for efficient therapeutics delivery.Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.Nasal delivery of fentanyl.Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.Preparation and characterisation of mucoadhesive nasal gel of venlafaxine hydrochloride for treatment of anxiety disorders.Newer drug delivery systems in anesthesia.
P2860
Q24601187-C400EBBD-58BF-4F04-8188-BFA31F6AFF17Q26776333-353F10C1-131A-41E3-8F22-1A02834B7DB9Q27007143-98C190BD-BC73-4A35-8489-0E8739924B86Q28539271-0C385A71-36A5-4365-9B93-DAC66663BFA4Q28539362-175342B3-9DC4-45F7-A350-09EB679C66F9Q30477576-2E6C5174-95AE-4653-A3A2-E510E2B5626DQ33604874-788DFF59-6E0D-4FFB-8324-80B5595A2590Q33726281-2231560D-70F4-4941-8551-AD7979E76833Q34280244-AF6D74DE-6B94-4729-B90F-015B53E828EEQ34291771-6D151199-F89C-4832-AAA1-88ADF47FC34FQ35088391-14406CE1-C466-436C-8A8A-799904E388FDQ35097008-79750836-E6D7-44CA-8064-4920123FFEE3Q35188768-115B3ADC-741A-4CB9-BABD-5FF7D518F8F4Q35295915-636E9BC9-7125-4D91-9362-21C07ACBDA92Q35388548-E2193ED6-8B5D-4940-9272-7BC8B9DCA823Q35547264-D358A061-AB23-4B40-B547-EDAA081C4F2AQ35625854-34FA029D-45FD-4CC8-A068-692248053DFCQ35685315-8575F773-CF86-4C77-9DB5-7EFB6F40EB4BQ36096447-AB431C4F-86D5-4EE2-BA1D-4403751F7F58Q36111963-F45CB2D6-F8EA-40A5-847F-8FAAE56F4348Q36521858-81D95538-7E5C-4E43-8AD5-795AF23DD756Q36600022-11196F5F-EE5E-4B1E-A9CB-1DF709BE6FFCQ36672718-7C0D194F-EBBB-4608-A211-462827EF4A79Q36866855-5614991A-FC28-4283-85DE-A92A6FA3A1E9Q37438511-7FA7800C-5FDF-4B96-BC46-BF54C4157D7DQ37593083-239415D2-ECD8-414F-B378-148EAAB77073Q37662764-E80156F6-0EF5-4E4D-899F-FE2C9279CFB6Q37748791-51846245-1294-409D-A309-3CF276674E5BQ37854450-B9002639-6A99-4D63-A4B5-88F95E29FD05Q37942690-DEAC1E28-B4AB-40E5-AEA7-19993D15C20CQ37976082-EDB2F458-180C-4784-9D44-4ABD748CA090Q38063947-2BC624F8-0BB9-4E65-8211-209350B1BE9BQ38162494-44AEBB9F-8E3E-412C-9389-4D0B8908FC76Q38217878-53B9E654-30FB-46AA-8465-3553A38BE77AQ38741041-FCB9A1AC-648F-4900-A24C-218272E25DA7Q39476518-7C9B2354-D47C-45BF-A2A2-83FFEAE8803BQ40335819-5DB7D8F6-0279-4563-95CA-743A25A3F44AQ40482585-61C8FC42-75E3-4660-9554-9D7A48C9CB27Q40919964-D4E93CC8-C456-4B35-9028-3C7AEDBD5BEBQ41081606-D353450B-A33E-4018-84AB-0B8B019EBD68
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nasal drug delivery: new developments and strategies.
@ast
Nasal drug delivery: new developments and strategies.
@en
type
label
Nasal drug delivery: new developments and strategies.
@ast
Nasal drug delivery: new developments and strategies.
@en
prefLabel
Nasal drug delivery: new developments and strategies.
@ast
Nasal drug delivery: new developments and strategies.
@en
P1433
P1476
Nasal drug delivery: new developments and strategies.
@en
P2093
Lisbeth Illum
P304
P356
10.1016/S1359-6446(02)02529-1
P577
2002-12-01T00:00:00Z